Taslima Mamataz1, Jamal Uddin2, Sayed Ibn Alam3, Rod S Taylor4, Maureen Pakosh5, Sherry L Grace6. 1. Faculty of Health, York University, Bethune 222B, 4700 Keele Street, Toronto, ON M3J 1P3, Canada. 2. Department of Cardiac Surgery, Ibrahim Cardiac Hospital & Research Institute (ICHRI), Shahbag, Dhaka, Bangladesh. 3. Videncenter for Rehabilitering og Palliation REHPA, University of South Denmark, Nyborg, Denmark. 4. MRC/CSO Social and Public Health Sciences Unit & Robertson Centre for Biostatistics, Institute of Health and Well Being, School of Medicine, Dentistry & Nursing, University of Glasgow, UK. 5. Library & Information Services, Toronto Rehabilitation Institute, University Health Network, University of Toronto, Toronto, ON, Canada. 6. Faculty of Health, York University, Bethune 368, 4700 Keele Street, Toronto, ON M3J 1P3, Canada; KITE & Peter Munk Cardiac Centre, University Health Network, University of Toronto, Toronto, ON, Canada. Electronic address: sgrace@yorku.ca.
Abstract
OBJECTIVES: To assess the effectiveness of cardiac rehabilitation (CR) in low- and middle-income countries (LMICs), given previous reviews have included scant trials from these settings and the great need there. METHODS: Six electronic databases (PubMed, Medline, Embase, CINAHL, Cochrane Library, and APA PsycINFO) were searched from inception-May 2020. Randomised controlled CR (i.e., at least initial assessment and structured exercise; any setting; some Phase II) trials with any clinical outcomes (e.g., mortality and morbidity, functional capacity, risk factor control and psychosocial well-being) or cost, with usual care (UC) control or active comparison (AC), in acute coronary syndrome with or without revascularization or heart failure patients in LMICs were included. With regard to data extraction and data synthesis, two reviewers independently vetted identified citations and extracted data from included trials; Risk of bias was assessed using Cochrane's tool. Certainty of evidence was ascertained based on the Grading of Recommendations Assessment, Development and Evaluation (GRADE) framework. A random-effects model was used to calculate weighted mean differences and 95% confidence intervals (CI). RESULTS: Twenty-six trials (6380 participants; 16.9% female; median follow-up = 3 months) were included. CR meaningfully improved functional capacity (VO2peak vs UC: 5 trials; mean difference [MD] = 3.13 ml/kg/min, 95% CI = 2.61 to 3.65; I2 = 9.0%); moderate-quality evidence), systolic blood pressure (vs UC: MD = -5.29 mmHg, 95% CI = -8.12 to -2.46; I2 = 45%; low-quality evidence), low-density lipoprotein cholesterol (vs UC: MD = -16.55 mg/dl, 95% CI = -29.97 to -3.14; I2 = 74%; very low-quality evidence), body mass index (vs AC: MD = -0.84 kg/m2, 95% CI = -1.61 to -0.07; moderate-quality evidence; I2 = 0%), and quality of life (QoL; vs UC; SF-12/36 physical: MD = 6.05, 95% CI = 1.77 to 10.34; I2 = 93%, low-quality evidence; mental: MD = 5.38, 95% CI = 1.13 to 9.63; I2 = 84%; low-quality evidence), among others. There were no evidence of effects on mortality or morbidity. Qualitative analyses revealed CR was associated with lower percutaneous coronary intervention, myocardial infarction, better cardiovascular function, and biomarkers, as well as return to life roles; there were other non-significant effects. Two studies reported low cost of home-based CR. CONCLUSIONS: Low to moderate-certainty evidence establishes CR as delivered in LMICs improves functional capacity, risk factor control and QoL. While more high-quality research is needed, we must augment access to CR in these settings. SYSTEMATIC REVIEW REGISTRATION: PROSPERO (CRD42020185296).
OBJECTIVES: To assess the effectiveness of cardiac rehabilitation (CR) in low- and middle-income countries (LMICs), given previous reviews have included scant trials from these settings and the great need there. METHODS: Six electronic databases (PubMed, Medline, Embase, CINAHL, Cochrane Library, and APA PsycINFO) were searched from inception-May 2020. Randomised controlled CR (i.e., at least initial assessment and structured exercise; any setting; some Phase II) trials with any clinical outcomes (e.g., mortality and morbidity, functional capacity, risk factor control and psychosocial well-being) or cost, with usual care (UC) control or active comparison (AC), in acute coronary syndrome with or without revascularization or heart failure patients in LMICs were included. With regard to data extraction and data synthesis, two reviewers independently vetted identified citations and extracted data from included trials; Risk of bias was assessed using Cochrane's tool. Certainty of evidence was ascertained based on the Grading of Recommendations Assessment, Development and Evaluation (GRADE) framework. A random-effects model was used to calculate weighted mean differences and 95% confidence intervals (CI). RESULTS: Twenty-six trials (6380 participants; 16.9% female; median follow-up = 3 months) were included. CR meaningfully improved functional capacity (VO2peak vs UC: 5 trials; mean difference [MD] = 3.13 ml/kg/min, 95% CI = 2.61 to 3.65; I2 = 9.0%); moderate-quality evidence), systolic blood pressure (vs UC: MD = -5.29 mmHg, 95% CI = -8.12 to -2.46; I2 = 45%; low-quality evidence), low-density lipoprotein cholesterol (vs UC: MD = -16.55 mg/dl, 95% CI = -29.97 to -3.14; I2 = 74%; very low-quality evidence), body mass index (vs AC: MD = -0.84 kg/m2, 95% CI = -1.61 to -0.07; moderate-quality evidence; I2 = 0%), and quality of life (QoL; vs UC; SF-12/36 physical: MD = 6.05, 95% CI = 1.77 to 10.34; I2 = 93%, low-quality evidence; mental: MD = 5.38, 95% CI = 1.13 to 9.63; I2 = 84%; low-quality evidence), among others. There were no evidence of effects on mortality or morbidity. Qualitative analyses revealed CR was associated with lower percutaneous coronary intervention, myocardial infarction, better cardiovascular function, and biomarkers, as well as return to life roles; there were other non-significant effects. Two studies reported low cost of home-based CR. CONCLUSIONS: Low to moderate-certainty evidence establishes CR as delivered in LMICs improves functional capacity, risk factor control and QoL. While more high-quality research is needed, we must augment access to CR in these settings. SYSTEMATIC REVIEW REGISTRATION: PROSPERO (CRD42020185296).
Authors: Sidney C Smith; Emelia J Benjamin; Robert O Bonow; Lynne T Braun; Mark A Creager; Barry A Franklin; Raymond J Gibbons; Scott M Grundy; Loren F Hiratzka; Daniel W Jones; Donald M Lloyd-Jones; Margo Minissian; Lori Mosca; Eric D Peterson; Ralph L Sacco; John Spertus; James H Stein; Kathryn A Taubert Journal: Circulation Date: 2011-11-03 Impact factor: 29.690
Authors: Sherry L Grace; Paul Poirier; Colleen M Norris; Garth H Oakes; Deborah S Somanader; Neville Suskin Journal: Can J Cardiol Date: 2014-04-12 Impact factor: 5.223
Authors: Mahshid Moghei; Ella Pesah; Karam Turk-Adawi; Marta Supervia; Francisco Lopez Jimenez; Ellen Schraa; Sherry L Grace Journal: Int J Cardiol Date: 2018-10-31 Impact factor: 4.164
Authors: Diann E Gaalema; Stephen T Higgins; Donald S Shepard; Jose A Suaya; Patrick D Savage; Philip A Ades Journal: J Cardiopulm Rehabil Prev Date: 2014 Jul-Aug Impact factor: 2.081
Authors: Ambalam M Chandrasekaran; Sanjay Kinra; Vamadevan S Ajay; Kaushik Chattopadhyay; Kalpana Singh; Kavita Singh; Pradeep A Praveen; Divya Soni; Raji Devarajan; Dimple Kondal; Subhash C Manchanda; Alun D Hughes; Nishi Chaturvedi; Ian Roberts; Stuart Pocock; Shah Ebrahim; Kolli S Reddy; Nikhil Tandon; Dorairaj Prabhakaran Journal: Int J Cardiol Date: 2019-01-07 Impact factor: 4.164
Authors: Linda Long; Ify R Mordi; Charlene Bridges; Viral A Sagar; Edward J Davies; Andrew Js Coats; Hasnain Dalal; Karen Rees; Sally J Singh; Rod S Taylor Journal: Cochrane Database Syst Rev Date: 2019-01-29
Authors: Sherry L Grace; Karam I Turk-Adawi; Aashish Contractor; Alison Atrey; Norm Campbell; Wayne Derman; Gabriela L Melo Ghisi; Neil Oldridge; Bidyut K Sarkar; Tee Joo Yeo; Francisco Lopez-Jimenez; Shanthi Mendis; Paul Oh; Dayi Hu; Nizal Sarrafzadegan Journal: Heart Date: 2016-05-15 Impact factor: 5.994
Authors: Mohiul I Chowdhury; Karam Turk-Adawi; Abraham Samuel Babu; Gabriela Lime de Melo Ghisi; Pamela Seron; Tee Joo Yeo; Jamal Uddin; Martin Heine; Marianna Garcia Saldivia; Evangelia Kouidi; Masoumeh Sadeghi; Raghdah Aljehani; Sherry L Grace Journal: Glob Heart Date: 2022-01-11
Authors: Joshua Garfein; Emily N Guhl; Gretchen Swabe; Akira Sekikawa; Emma Barinas-Mitchell; Daniel E Forman; Jared W Magnani Journal: J Am Heart Assoc Date: 2022-06-22 Impact factor: 6.106
Authors: Jacek Hincz; Maciej Sterliński; Dariusz Kostrzewa; Rafał Dąbrowski; Edyta Smolis-Bąk Journal: Int J Environ Res Public Health Date: 2022-09-02 Impact factor: 4.614